Adverse respiratory effects of opioids for chronic breathlessness: to what extent can we learn lessons from chronic pain?
- PMID: 30026306
- DOI: 10.1183/13993003.00882-2018
Adverse respiratory effects of opioids for chronic breathlessness: to what extent can we learn lessons from chronic pain?
Conflict of interest statement
Conflict of interest: C.A. Verberkt reports receiving grants from ZonMW, the Hague, during the conduct of the study. Conflict of interest: M.J. Johnson's institution has received payment from Mayne Pharma for clinical consultancy, during the conduct of the study. Conflict of interest: E.F.M. Wouters has received personal fees for board membership from Nycomed and Boehringer, grants from AstraZeneca and GSK, and payments for lectures from AstraZeneca, GSK, Novartis and Chiesi. Conflict of interest: D.J.A. Janssen reports receiving grants from ZonMw, the Hague, during the conduct of the study; lecture fees from Boehringer Ingelheim, GSK, AstraZeneca, Almirall and Chiesi, and a consultancy fee from MaynePharma, outside the submitted work. Conflict of interest: M.H.J. van den Beuken-van Everdingen reports grants from ZonMw, during the conduct of the study.
Comment on
-
Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis.Eur Respir J. 2017 Nov 22;50(5):1701153. doi: 10.1183/13993003.01153-2017. Print 2017 Nov. Eur Respir J. 2017. PMID: 29167300
-
Adverse respiratory effects of opioids for chronic breathlessness: learning lessons from chronic pain.Eur Respir J. 2018 Mar 1;51(3):1702531. doi: 10.1183/13993003.02531-2017. Print 2018 Mar. Eur Respir J. 2018. PMID: 29496786 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical